Pharmaceutical Sciences

Pharmaceutical Sciences Experts

Frank Torti

Pharmaceutical Sciences
Galera Therapeutics Inc.
United States of America


Dr. Torti joined NEA in 2007 and focuses on investments in biopharmaceuticals, medical devices, and healthcare services. He has been actively involved in the firm’s private and public investments in healthcare, including Peplin (acquired by LEO Pharma), CITIC Pharmaceuticals (acquired by Shanghai Pharmaceuticals), Alimera Sciences, Cadence Pharmaceuticals, Dermira, Galera Therapeutics, Neotract, Novast Pharmaceuticals, Rigel Pharmaceuticals, and Solta Medical. Dr. Torti received his MD from the University of North Carolina School of Medicine, his MBA with distinction from Harvard Business School, and his BA with highest honors from the University of North Carolina, where he was a Morehead Scholar.

Research Interest

Host defense mechanisms,LPS effects on neurotransmitters  

Global Experts from United States of America

Global Experts in Subject